- $868.41m
- $580.49m
- 46
- 32
- 82
- 53
Annual balance sheet for GH Research, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 5.89 | 277 | 166 | 162 | 149 |
| Net Total Receivables | — | 0.048 | 0.09 | 0.178 | 0.15 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5.91 | 280 | 169 | 164 | 154 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | 0.082 | 0.097 | 1.07 | 0.748 |
| Long Term Investments | |||||
| Total Assets | 5.91 | 280 | 254 | 226 | 188 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.246 | 2.75 | 4.55 | 6.7 | 8.95 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.246 | 2.75 | 4.55 | 7.33 | 9.32 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 5.67 | 277 | 250 | 219 | 179 |
| Total Liabilities & Shareholders' Equity | 5.91 | 280 | 254 | 226 | 188 |
| Total Common Shares Outstanding |